Both origin hypotheses remain live, and neither has direct proof. The strongest case for a research-related origin is circumstantial but non-trivial. Here are the arguments proponents consider strongest, roughly in order of how much weight they carry in the scientific debate:
**1. Geographic coincidence**
The outbreak began in Wuhan, home to the Wuhan Institute of Virology (WIV) — the world's leading collection and research program for SARS-related bat coronaviruses. Wuhan is roughly 1,000–1,500 km from the caves in southern China and Southeast Asia where the closest known relatives of SARS-CoV-2 circulate in horseshoe bats. Sarbecovirus spillover risk is concentrated in rural areas of Yunnan, Laos, and Myanmar, not in a central-Chinese megacity. Proponents argue the prior probability of an outbreak starting in the one city with the relevant lab is low. Critics respond that Wuhan is a major hub for wildlife trade and travel, and that a spillover in a rural village might smolder undetected until reaching a city.
**2. Documented interest in exactly the kind of virus that emerged**
The 2018 "DEFUSE" proposal (EcoHealth Alliance, WIV, and collaborators, submitted to DARPA) proposed constructing chimeric bat coronaviruses and — notably — inserting proteolytic cleavage sites into spike proteins to test for enhanced infectivity. It was not funded, and the specific work described doesn't match SARS-CoV-2's genome. But it establishes that researchers in this network were contemplating the modification of sarbecovirus spikes shortly before a novel sarbecovirus with an unusual spike appeared. WIV also conducted some coronavirus work at BSL-2, and had collected thousands of unpublished bat samples.
**3. The furin cleavage site**
SARS-CoV-2 has a polybasic furin cleavage site (PRRAR) at the S1/S2 junction that no other known sarbecovirus possesses, and it substantially enhances infectivity. Counterpoint: furin sites are common across other coronavirus lineages (MERS, HKU1, mouse hepatitis virus) and can arise by recombination or insertion; the related codon-usage arguments (e.g., the CGG-CGG pair) are generally considered weak, since such codons appear elsewhere in related genomes.
**4. No animal source has been found**
For SARS-CoV-1, infected palm civets were identified within months; for MERS, camels. For SARS-CoV-2, despite testing of tens of thousands of animals, no infected intermediate host, no infected animal from the Huanan market, and no positive upstream farm or supply chain has been identified. This absence is the argument natural-origin researchers find hardest to dismiss, though they note China's testing was late, incomplete, and that market animals were culled before sampling.
**5. Intelligence assessments and reported incidents**
The FBI (moderate confidence) and Department of Energy (low confidence) favor a research-related incident; the CIA has also reportedly leaned that way with low confidence. Reporting and a 2021 State Department fact sheet allege several WIV researchers fell ill in autumn 2019, though this has never been publicly substantiated. Other U.S. agencies and the National Intelligence Council favor natural zoonosis, also with low confidence — the community is genuinely split, which itself indicates the evidence is thin in both directions.
**6. Opacity**
WIV's viral sequence database was taken offline in September 2019; key samples and records (including from the Mojiang mine where RaTG13 was found) have not been released; WHO investigators were denied raw data and access. Some early Wuhan sequences were deleted from public databases. This is evidence of concealment, not of lab origin per se — but it prevents the kind of audit that could resolve the question.
**The main counterweights**
For balance, the strongest natural-origin evidence: the earliest known cases cluster spatially around the Huanan Seafood Market more tightly than around the WIV; positive environmental samples at the market co-locate with genetic material from susceptible wild mammals like raccoon dogs; live susceptible animals were sold there via documented trade pipelines; two distinct early lineages (A and B) suggest multiple introductions from a common animal reservoir; and there is no record, publication, or sample showing SARS-CoV-2 or a close progenitor in any laboratory — a lab origin requires positing an unknown, unpublished precursor virus.
**Bottom line**
The lab-origin case rests almost entirely on circumstance, plausibility, and absence of an animal host; the zoonotic case rests on epidemiological patterns around the market and the overwhelming historical base rate of natural spillover. Resolving it would likely require access to WIV's sample inventories and records, or the discovery of an infected animal population — neither of which appears forthcoming. Anyone claiming certainty in either direction is going beyond the public evidence.